EMA to Juggle Brexit and New Quality and Safety Guidelines

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency’s quality and safety working groups intend to tackle several new guidelines this year, covering the sterilization of products and containers, risk-based prevention of cross contamination in manufacturing and requirements for products containing a device delivery component.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor